69 related articles for article (PubMed ID: 12733375)
1. [Expression of C-myc and N-myc protein in adulthood and childhood medulloblastomas and prognostic analysis].
Liu Y; Mao B; Hokeung N; Chen Y; Gao L
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):120-2. PubMed ID: 12733375
[TBL] [Abstract][Full Text] [Related]
2. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical analysis of medulloblastoma and PNET with emphasis on N-myc protein expression.
Moriuchi S; Shimizu K; Miyao Y; Hayakawa T
Anticancer Res; 1996; 16(5A):2687-92. PubMed ID: 8917371
[TBL] [Abstract][Full Text] [Related]
4. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical markers for prognosis of average-risk pediatric medulloblastomas. The effect of apoptotic index, TrkC, and c-myc expression.
Korshunov A; Savostikova M; Ozerov S
J Neurooncol; 2002 Jul; 58(3):271-9. PubMed ID: 12187960
[TBL] [Abstract][Full Text] [Related]
6. A clinicobiological model predicting survival in medulloblastoma.
Ray A; Ho M; Ma J; Parkes RK; Mainprize TG; Ueda S; McLaughlin J; Bouffet E; Rutka JT; Hawkins CE
Clin Cancer Res; 2004 Nov; 10(22):7613-20. PubMed ID: 15569993
[TBL] [Abstract][Full Text] [Related]
7. C-MYC expression in medulloblastoma and its prognostic value.
Herms J; Neidt I; Lüscher B; Sommer A; Schürmann P; Schröder T; Bergmann M; Wilken B; Probst-Cousin S; Hernáiz-Driever P; Behnke J; Hanefeld F; Pietsch T; Kretzschmar HA
Int J Cancer; 2000 Sep; 89(5):395-402. PubMed ID: 11008200
[TBL] [Abstract][Full Text] [Related]
8. Parsing Myc Paralogs in Oncogenesis.
Mathsyaraja H; Eisenman RN
Cancer Cell; 2016 Jan; 29(1):1-2. PubMed ID: 26766585
[TBL] [Abstract][Full Text] [Related]
9. Survivin is a negative prognostic marker in medulloblastoma.
Pizem J; Cört A; Zadravec-Zaletel L; Popovic M
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
[TBL] [Abstract][Full Text] [Related]
10. [An immunohistochemical study of tenascin expression in cerebellar medulloblastomas].
Korshunov AG; Golanov AV; Sycheva RV
Zh Vopr Neirokhir Im N N Burdenko; 1997; (4):23-7. PubMed ID: 9460893
[TBL] [Abstract][Full Text] [Related]
11. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
[TBL] [Abstract][Full Text] [Related]
12. Correlation of gamma-catenin expression with good prognosis in medulloblastomas.
Misaki K; Marukawa K; Hayashi Y; Fukusato T; Minamoto T; Hasegawa M; Yamashita J; Fujisawa H
J Neurosurg; 2005 Mar; 102(2 Suppl):197-206. PubMed ID: 16156230
[TBL] [Abstract][Full Text] [Related]
13. [Expression of KDR in medulloblastoma and its clinical implication].
Cheng H; Mao B; Zhang S; Cheng N
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):369-71. PubMed ID: 12536566
[TBL] [Abstract][Full Text] [Related]
14. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
[TBL] [Abstract][Full Text] [Related]
15. The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity.
Vo BT; Wolf E; Kawauchi D; Gebhardt A; Rehg JE; Finkelstein D; Walz S; Murphy BL; Youn YH; Han YG; Eilers M; Roussel MF
Cancer Cell; 2016 Jan; 29(1):5-16. PubMed ID: 26766587
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
[TBL] [Abstract][Full Text] [Related]
17. Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression.
de Haas T; Hasselt N; Troost D; Caron H; Popovic M; Zadravec-Zaletel L; Grajkowska W; Perek M; Osterheld MC; Ellison D; Baas F; Versteeg R; Kool M
Clin Cancer Res; 2008 Jul; 14(13):4154-60. PubMed ID: 18593994
[TBL] [Abstract][Full Text] [Related]
18. Potential prognostic value of C-erbB-2 expression in medulloblastomas in very young children.
Herms JW; Behnke J; Bergmann M; Christen HJ; Kolb R; Wilkening M; Markakis E; Hanefeld F; Kretzschmar HA
J Pediatr Hematol Oncol; 1997; 19(6):510-5. PubMed ID: 9407936
[TBL] [Abstract][Full Text] [Related]
19. Morphophenotype of medulloblastoma in children and adults. The size of nuclei.
Dagostino C; Clara E; Chio A; Giordana MT
Clin Neuropathol; 2006; 25(5):227-31. PubMed ID: 17007445
[TBL] [Abstract][Full Text] [Related]
20. Elevated c-myc expression in childhood medulloblastomas.
MacGregor DN; Ziff EB
Pediatr Res; 1990 Jul; 28(1):63-8. PubMed ID: 2198527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
